TLR4 and Alzheimer disease: Our results showed that inhibiting endothelial TLR4 signaling pathway could not only suppress the inflammation activated by Aβ but also reverse other Aβ‐induced alterations, indicating the possibility of inflammatory pathway as the target for CAA/AD treatment.